Showing results (1301-1310 of 1,373) with videos related to
Sort By:
Pageof 138
Leukemia|January 15, 2025
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA studyPhilippe Moreau, Thierry Facon, Saad Z Usmani, et al.Leukemia|July 30, 2011
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group studyS K Kumar, J H Lee, J J Lahuerta, et al.Bone Marrow Transplantation|May 10, 2023
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMTMeral Beksac, Simona Iacobelli, Linda Koster, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2016
Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST TrialCyrille Hulin, Andrew Belch, Chaim Shustik, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2013
The translocation t(4;14) can be present only in minor subclones in multiple myelomaBenjamin Hébraud, Denis Caillot, Jill Corre, et al.Stroke|December 7, 2020
Computed Tomography Perfusion-Based Machine Learning Model Better Predicts Follow-Up Infarction in Patients With Acute Ischemic StrokeHulin Kuang, Wu Qiu, Anna M Boers, et al.Leukemia & Lymphoma|July 13, 2017
Heavy + light chain analysis to assign myeloma response is analogous to the IMWG response criteriaGuillemette Fouquet, Kym Ie Snell, Stéphanie Guidez, et al.Leukemia|July 13, 2007
Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trialsP Moreau, M Attal, F Garban, et al.Blood|January 16, 2013
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02Xavier Leleu, Michel Attal, Bertrand Arnulf, et al.The New England Journal of Medicine|April 6, 2017
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for MyelomaMichel Attal, Valerie Lauwers-Cances, Cyrille Hulin, et al.Pageof 138